The des‐γ‐carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma
Open Access
- 4 December 2003
- Vol. 98 (12), 2671-2677
- https://doi.org/10.1002/cncr.11839
Abstract
BACKGROUND Des‐γ‐carboxy prothrombin (DCP) has been reported to be an important prognostic factor in patients with hepatocellular carcinoma (HCC). Recently, a monoclonal antibody, 19B7, which recognizes the Gla domain of DCP, has been identified. The 19B7 antibody recognizes an epitope different from that recognized by MU‐3, which is another antibody against DCP. In this study, the authors investigated the measurement of DCP using the antibodies MU‐3 and 19B7, respectively, as a prognostic factor for patients with HCC who had solitary, small tumors and or Child Stage A HCC. METHODS One hundred four patients with HCC who had solitary, small tumors or Child Stage A tumors were enrolled in the study between 1991 and 2001. All patients were treated and were followed for a mean of 3.2 years. The authors analyzed the correlation between the DCP Index (DCP measured by MU‐3 and DCP measured by 19B7) and patient prognosis. The patients were classified into 3 groups based on their DCP Index: 1) DCP negative (DCP < 40 milli arbitrary unit (mAU)/mL)); 2) low DCP Index (DCP ≥ 40 mAU/mL; MU‐3:19B7 ratio, < 3.0; and 3) high DCP Index (DCP ≥ 40 mAU/mL; MU‐3:19B7 ratio, ≥ 3.0). RESULTS The survival rate for patients in the high DCP Index group was lower compared with the survival rate for patients in the DCP‐negative group and was significantly lower compared with the survival rate for patients in the low DCP Index group. In a univariate Cox proportional hazards model, the positive factors were high DCP Index and low DCP Index. Among the positive predictive factors that were analyzed using a multivariate Cox proportional hazards model were age (hazard ratio, 3.27; P = 0.006), low DCP Index (hazard ratio, 2.87; P = 0.012), and high DCP Index (hazard ratio, 12.3; P < 0.0001). CONCLUSIONS The prognosis of patients who had a high DCP Index score was poorer compared with patients who had a low DCP Index score and patients who were classified as DCP negative. The authors concluded that the DCP Index is a prognostic indicator for patients with HCC. Cancer 2003;98:2671–7. © 2003 American Cancer Society.Keywords
This publication has 23 references indexed in Scilit:
- The role of des-γ-carboxy prothrombin levels in hepatocellular carcinoma and liver tissuesCancer Letters, 2000
- Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinomaBritish Journal of Surgery, 1999
- The fucosylation index of ?-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinomaCancer, 1998
- Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinomaCancer, 1996
- Prognostic significance of Lens culinaris agglutinin A-reactive alpha- fetoprotein in small hepatocellular carcinomasGastroenterology, 1996
- The growth inhibitory effects of vitamins K and their actions on gene expressionHepatology, 1995
- Levels of vitamin K, immunoreactive prothrombin, des‐γ‐carboxy prothrombin and γ‐glutamyl carboxylase activity in hepatocellular carcinoma tissueJournal of Gastroenterology and Hepatology, 1995
- Characteristics of the PIVKA-II found in hepatocellular carcinoma, investigation using monoclonal antibodies MU-3 and 19B7International Hepatology Communications, 1994
- Plasma des-γ-carboxyprothrombin in the early stage of hepatocellular carcinomaHepatology, 1990
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973